IP Library Patent Application 14157088
Patent Application
App. No. 14/157,088

METHOD AND KIT FOR TREATMENT OF TISSUE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/157,088
Abstract

Methods for creating a desired tissue effect. An RF electrode is provided that includes a conductive portion. The RF electrode is coupled to a fluid delivery member that delivers a cooling fluidic medium to a back surface of the RF electrode. A dielectric is positioned on a skin surface. The RF electrode is coupled with the dielectric. RF energy is delivered from the RF electrode and the dielectric to the skin surface.

Claims (22)

1 . A method for creating a desired tissue effect using an RF electrode that includes a conductive portion, the method comprising:

positioning a dielectric on a skin surface;

coupling the RF electrode on the dielectric; and

delivering RF energy from the conductive portion of the RF electrode to tissue beneath a skin surface by capacitive coupling through the dielectric and into the skin surface.

2 . The method of claim 1 , wherein the RF electrode is positioned on the dielectric.

3 . The method of claim 1 , wherein the RF electrode is coupled to a support structure.

4 . The method of claim 1 , wherein the RF energy is delivered to the tissue without creating substantial necrosis at the skin surface.

5 . The method of claim 1 , further comprising:

cooling a back surface of the RF electrode.

6 . The method of claim 1 , further comprising:

supplying an atomizing delivery of a cooling fluidic medium to the back surface of the RF electrode.

7 . The method of claim 1 , further comprising:

evaporatively cooling the back surface of the RF electrode with a cooling fluidic medium; and

conductively cooling the skin surface in contact with the dielectric.

8 . The method of claim 1 , wherein the desired tissue effect is selected from the group consisting of skin remodeling, skin resurfacing, wrinkle removal, treatment of the sebaceous glands, treatment of hair follicles, treatment of adipose tissue, treatment of acne, and treatment of spider veins.

9 . The method of claim 1 , further comprising:

creating a reverse thermal gradient on at least a portion of the skin surface, the reverse thermal gradient cooling the skin surface while heating the tissue, wherein a temperature of the skin surface is lower than a temperature of the tissue.

10 . The method of claim 1 , further comprising:

creating a reverse thermal gradient through at least a portion of the skin surface where a temperature of the skin surface is lower than collagen in the tissue.

11 . The method of claim 1 , wherein delivering RF energy comprises:

directing RF energy through the skin surface to the tissue for a sufficient time to induce a change in collagen in the tissue while minimizing cellular necrosis at the skin surface to create the desired tissue effect.

12 . The method of claim 1 , wherein the conductive portion of the RF electrode includes a metal.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY INTEREST Recorded Jul 18, 2016
From: SOLTA MEDICAL, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039178/0970 →